ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

RPTX Repare Therapeutics Inc

3.26
0.00 (0.00%)
Pre Market
Last Updated: 18:19:25
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
CAD ($)CAD ($)USD (US$)USD (US$)
Total Revenue 408k679k112.55M18.2M5.68M30.25M2.16M13.05M
Operating Income -34.83M-38.73M73.4M-19.63M-34.68M-12.26M-38.42M-30.87M
Pre Tax Income -34.73M-38.06M75.52M-16.63M-31.33M-8.84M-35.18M-27.84M
Net Income -34.76M-38.09M75.46M-31.66M-34.94M-11.95M-18.88M-28.03M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -34.84M-38.75M73.36M-19.62M-34.7M-12.28M-38.45M-30.91M
EBITDA -34.31M-38.21M73.88M-19.18M-34.24M-11.75M-37.92M-30.36M
Year End 31 December 2023 2020202120222023
CAD ($)CAD ($)USD (US$)USD (US$)
Total Revenue 135k7.6M131.83M51.13M
Operating Income -54.3M-108.66M-19.8M-116.22M
Pre Tax Income -54.74M-108.59M-13.9M-103.18M
Net Income -53.42M-106.91M-29.05M-93.8M
Preferred Dividends 0000
Basic Earnings Per Share (EPS) -1.448-2.555-0.691-2.193
EBIT -54.32M-108.7M-19.84M-116.34M
EBITDA -53.41M-107.19M-17.82M-114.27M

Your Recent History

Delayed Upgrade Clock